Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;3(1):e356.
doi: 10.1371/journal.pntd.0000356. Epub 2009 Jan 13.

Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking

Affiliations

Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking

Dariusz Ekonomiuk et al. PLoS Negl Trop Dis. 2009.

Abstract

Background: The non-structural 3 protease (NS3pro) is an essential flaviviral enzyme and therefore one of the most promising targets for drug development against West Nile virus (WNV) and dengue infections.

Methodology: In this work, a small-molecule inhibitor of the WNV NS3pro has been identified by automatic fragment-based docking of about 12000 compounds and testing by nuclear magnetic resonance (NMR) spectroscopy of only 22 molecules. Specific binding of the inhibitor into the active site of NS3pro and its binding mode are confirmed by 15N-HSQC NMR spectra. The inhibitory activity is further validated by an enzymatic assay and a tryptophan fluorescence quenching assay.

Conclusion: The inhibitor [4-(carbamimidoylsulfanylmethyl)-2,5-dimethylphenyl]-methylsulfanylmethanimidamide has a good ratio of binding affinity versus molecular weight (ligand efficiency of 0.33 kcal/mol per non-hydrogen atom), and thus has good potential as lead compound for further development to combat West Nile virus infections.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Comparison of the calculated versus experimental binding free energies for 37 peptidic inhibitors of the WNV protease .
Peptide sequences are listed in Table S-I (found in Text S1). The solid diagonal is the ideal line of perfect prediction. The dashed diagonals delimit the 1 kcal/mol error region.
Figure 2
Figure 2. Schematic picture of the in silico screening campaign.
Docking of the 11715 compounds with one more positive charges or at least five hydrogen bond donors was performed by DAIM/SEED/FFLD using the 2fp7 structure of the WNV protease as explained in the text.
Figure 3
Figure 3. Compound 1, according to 1H chemical shifts (see Figure 4).
Figure 4
Figure 4. Binding affinity of compound 1 to WNV NS2B(K96A)-NS3pro.
The changes in 1H chemical shifts of the backbone amide protons of Thr52 and Glu101 were plotted as a function of increasing concentration of compound 1. A 10 mM stock solution of compound 1 was titrated into a 80 µM solution of 15N/13C-labeled NS2B(K96A)-NS3pro containing 20 mM phosphate (pH 7.0) and 2 mM DTT. The 15N-HSQC spectra were recorded at 25°C on an 800 MHz NMR spectrometer. The formula image value derived from the fitting curves is about 40 µM (30±10 and 50±10 µM for the cross-peaks of Thr52 and Glu101, respectively).
Figure 5
Figure 5. Superimposition of 15N-HSQC spectra of WNV NS2B(K96A)-NS3pro in the absence (red) and presence (blue) of compound 1 at 25°C.
The resonance assignments are shown for selected peaks. The samples contained 0.9 mM protein in 90% H2O/10% D2O, 20 mM HEPES buffer (pH 7.0), 2 mM DTT. The complex with compound 1 was prepared by titrating the protein solution with a single addition of 15 µl of a DMSO solution of compound 1 to a final concentration of 3 mM. The spectra were recorded at a 1H NMR frequency of 800 MHz.
Figure 6
Figure 6. Binding mode of compound 1.
(Top) Interactions between compound 1 and WNV protease. The atoms of the protein and ligand are shown as balls and colored as carbon in black, oxygen in red, nitrogen in blue, and sulfur in yellow. Intermolecular hydrogen bonds are shown by green dashed lines with distances in Å. The intermolecular van der Waals contacts interactions (distance ≤4 Å) are shown in red dashed lines. (Figure made by Ligplot [67]). (Bottom) Stereoview of the binding mode of 1. The protease is shown as cartoon and its secondary structure is emphasized by different colors: formula image helices in red, formula image strands in yellow, and loops in green. Atoms of compound 1 are colored as in the (top) with hydrogens in black. This figure was prepared using PyMOL (Delano Scientific, San Carlos, CA).
Figure 7
Figure 7. The protease surface (PDB code 2FP7) is colored according to atomic partial charges.
(Left): Binding mode of the propylamine derivative of compound 1. Compound 1 and its propylamine derivative are in magenta and colored by atom type, respectively. (Right): Binding mode of the nitrophenyl derivative of compound 1. The substrate 2-naphthoyl-KKR-pNA and the nitrophenyl derivative of compound 1 are in white and colored by atom type, respectively. The binding mode of the substrate is modelled based on Ref. 4 and only part of it is shown for clarity. These figures were prepared using PyMOL (Delano Scientific, San Carlos, CA).

References

    1. Division of Vector-Borne Infectious Disease. West Nile virus homepage. 2007. Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvbid/westnile.
    1. Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Ann Rev Med. 2006;57:181–194. - PubMed
    1. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol. 2005;3:13–22. - PubMed
    1. Chappell KJ, Stoermer MJ, Fairlie DP, Young PR. Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies. J Biol Chem. 2006;281:38448–38458. - PubMed
    1. Perni RB, Almquist SJ, Byrn RA, Chandorkar G, Chaturvedi PR, et al. Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease. Antimicrob Agents Chemother. 2006;50:899–909. - PMC - PubMed

MeSH terms

Substances